JPMorgan is making its JPM Coin, a digital token representing U.S. dollar deposits, available on the Ethereum blockchain for institutional customers. This expansion allows users to make payments and settlements onchain at any time, including outside normal banking hours, enhancing speed and accessibility. Initially launched on Base in 2025, JPM Coin on Ethereum targets large crypto industry clients and financial institutions for onchain payments and tokenized asset trades. This move broadens JPMorgan's blockchain offerings and supports faster, blockchain-based dollar transactions for institutions.
JPMorgan's JPM Coin expansion on Ethereum coincides with a day where 36 out of 50 major cryptocurrencies on Pluang rose. For readers following crypto markets, here is Pluang's snapshot as of Oct 19, 2026 14:01 WIB: SAND (The Sandbox) traded at Rp1.088 with a 5.55% decline and a 35% sell order activity; CRV (Curve DAO Token) rose 5.50% to Rp6.405 with 43% sell orders; UNI (Uniswap) increased 2.91% to Rp132.881 despite 86% sell orders. Typical hold times ranged from 62 to 123 days across these assets.
Jyske Bank has repurchased shares valued at approximately DKK 2.15 billion as part of its ongoing share buyback program running from February 2026 to January 2027. The bank has acquired a total of 2,235,959 treasury shares, representing 3.84% of its ...
Jyske Bank is conducting a share buyback program from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-October 2026, the bank has repurchased shares worth approximately DKK 2.15 billion at an average price of DK...
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
